إعلان
إعلان

NNVC

NNVC logo

NanoViricides Inc.

1.13
USD
برعاية
-0.08
-6.45%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

1.21

+0.07
+6.45%

تقارير أرباح NNVC

النسبة الإيجابية المفاجئة

NNVC تفوق 12 من 13 آخر التقديرات.

92%

التقرير التالي

بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.14
التغير الضمني من Q1 26 (Revenue/ EPS)
--
/
+40.00%
التغير الضمني من Q2 25 (Revenue/ EPS)
--
/
--

NanoViricides Inc. earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, NNVC reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 45.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 المحللين forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an زيادة of 40.00% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q1 2026, NanoViricides Inc. reported EPS of -$0.10, beating estimates by 45.53%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.82%, changed from $1.42 before the earnings release to $1.46 the day after.
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
Based on 4 المحللين, NanoViricides Inc. is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان